PANews reported on September 22nd that Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its first purchase of Solana (SOL) tokens as part of its digital asset arbitrage strategy. The company currently holds over 760,190 SOL tokens at an average cost basis of $231. Additionally, the company holds over $335 million in cash, which it plans to use to further its digital asset arbitrage strategy. According to previous news, Helius has cooperated with Pantera Capital and others to raise more than US$500 million in financing and will launch the SOL treasury company .PANews reported on September 22nd that Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its first purchase of Solana (SOL) tokens as part of its digital asset arbitrage strategy. The company currently holds over 760,190 SOL tokens at an average cost basis of $231. Additionally, the company holds over $335 million in cash, which it plans to use to further its digital asset arbitrage strategy. According to previous news, Helius has cooperated with Pantera Capital and others to raise more than US$500 million in financing and will launch the SOL treasury company .

Publicly listed company Helius has begun purchasing SOL tokens and now holds over 760,000 SOL

2025/09/22 19:43

PANews reported on September 22nd that Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its first purchase of Solana (SOL) tokens as part of its digital asset arbitrage strategy. The company currently holds over 760,190 SOL tokens at an average cost basis of $231. Additionally, the company holds over $335 million in cash, which it plans to use to further its digital asset arbitrage strategy.

According to previous news, Helius has cooperated with Pantera Capital and others to raise more than US$500 million in financing and will launch the SOL treasury company .

Market Opportunity
Solana Logo
Solana Price(SOL)
$130.91
$130.91$130.91
+0.34%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.